The 66th American Society of Hematology (ASH) Annual Meeting & Exposition took place December 7-10, 2024, in San Diego, California; the 2025 meeting is currently scheduled to take place in Orlando ...
This interview will appear in the January 2025 issue of Evidence-Based Oncology, our annual recap of the American Society of ...
Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting ...
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.
The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the ...
Mendus AB ("Mendus" publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, announces a summary of the feedback received from the US Food and Drug Administr ...
"Coffee does not seem to worsen AFib, so there is no need to stop drinking it," said Joglar, who was not involved in the new ...
Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.
Researchers developed a novel calculator may help to tailor pain medication regimens to patients with SCD seeking emergency ...
As 2024 begins, many are focusing on healthier diets and fitness resolutions. Is Climate Change Secretly Sabotaging Your 2025 ...